Jacobson Pharma Corporation Limited (2633.HK)

HKD 1.01

(0.0%)

Inventory Summary of Jacobson Pharma Corporation Limited

  • Jacobson Pharma Corporation Limited's latest annual inventory in 2023 was 317.85 Million HKD , down -13.63% from previous year.
  • Jacobson Pharma Corporation Limited's latest quarterly inventory in 2023 FY was 317.85 Million HKD , down -13.63% from previous quarter.
  • Jacobson Pharma Corporation Limited reported annual inventory of 368 Million HKD in 2022, up 16.99% from previous year.
  • Jacobson Pharma Corporation Limited reported annual inventory of 314.55 Million HKD in 2021, down -11.69% from previous year.
  • Jacobson Pharma Corporation Limited reported quarterly inventory of 317.85 Million HKD for 2023 FY, down -13.63% from previous quarter.
  • Jacobson Pharma Corporation Limited reported quarterly inventory of 317.85 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of Jacobson Pharma Corporation Limited (2023 - 2013)

Historical Annual Inventory of Jacobson Pharma Corporation Limited (2023 - 2013)

Year Inventory Inventory Growth
2023 317.85 Million HKD -13.63%
2022 368 Million HKD 16.99%
2021 314.55 Million HKD -11.69%
2020 356.18 Million HKD -4.11%
2019 371.45 Million HKD 11.27%
2018 333.83 Million HKD 5.53%
2017 316.32 Million HKD 21.05%
2016 261.31 Million HKD 32.7%
2015 196.91 Million HKD 16.46%
2014 169.08 Million HKD 5.44%
2013 160.36 Million HKD 0.0%

Peer Inventory Comparison of Jacobson Pharma Corporation Limited

Name Inventory Inventory Difference
Pak Fah Yeow International Limited 12.19 Million HKD -2506.026%
Grand Pharmaceutical Group Limited 1.38 Billion HKD 77.11%
Extrawell Pharmaceutical Holdings Limited 7.26 Million HKD -4275.182%
Wai Yuen Tong Medicine Holdings Limited 308.09 Million HKD -3.167%
Qianhai Health Holdings Limited 431.78 Million HKD 26.386%
Lee's Pharmaceutical Holdings Limited 298.1 Million HKD -6.625%
Essex Bio-Technology Limited 62.82 Million HKD -405.965%
Tongfang Kontafarma Holdings Limited 98.26 Million HKD -223.466%
PuraPharm Corporation Limited 175.59 Million HKD -81.015%
SSY Group Limited 1.08 Billion HKD 70.739%
JBM (Healthcare) Limited 91.58 Million HKD -247.062%
China Resources Pharmaceutical Group Limited 35.09 Billion HKD 99.094%